Vacinas
Alemanha emite recomendação quanto à mistura de vacinas contra Covid-19.
5 Jul, 2021 | 10:15hGermany issues world’s strongest recommendation for mixing Covid-19 vaccines – CNN
[Preprint] Estudo mostra que misturar vacinas contra Covid traz uma boa resposta imunológica – “O estudo Com-Cov pesquisou a eficácia de 2 doses da vacina da Pfizer, 2 da AstraZeneca e também uma de cada. Todas as combinações funcionaram bem em preparar o sistema imune.”
2 Jul, 2021 | 11:19hMixing Covid jabs has good immune response, study finds – BBC
Estudo original (preprint): Safety and Immunogenicity Report from the Com-COV Study – a Single-Blind Randomised Non-Inferiority Trial Comparing Heterologous And Homologous Prime-Boost Schedules with An Adenoviral Vectored and mRNA COVID-19 Vaccine – SSRN Preprints with the Lancet
Trombocitopenia trombótica imune induzida por vacina (vaccine-induced immune thrombotic thrombocytopenia – VITT) – Uma nova entidade clinicopatológica com apresentações clínicas heterogêneas.
2 Jul, 2021 | 11:17hComentário: Blood clots related to AstraZeneca/Oxford vaccine can be mitigated with early detection – MedicalXpress
[Comunicado de imprensa] Vacina da J&J de dose única gera atividade forte e persistente contra a variante Delta e outras variantes do SARS-CoV-2 altamente prevalentes.
2 Jul, 2021 | 11:16hComunicado de imprensa: Positive New Data for Johnson & Johnson Single-Shot COVID-19 Vaccine on Activity Against Delta Variant and Long-lasting Durability of Response
Comentário: J&J Covid Shot Neutralizes Delta Variant, Company Says – Bloomberg (poucos artigos gratuitos por mês)
Ponto de vista | Compartilhamento de tecnologia e doses de vacina para combater a desigualdade global de vacinação e alcançar o fim da pandemia de COVID-19.
2 Jul, 2021 | 11:14hVacinas contra COVID-19 reduzem a gravidade, a duração e a carga viral daqueles que se infectam mesmo após a vacinação.
1 Jul, 2021 | 10:21hEstudo original: Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines – New England Journal of Medicine
Comentário no Twitter
The @CDCgov trial to rigorously assess mRNA vaccination suppression of covid infections as assessed with frequent NP swabs in nearly 4,000 participants
91% efficacy of blocking transmission of infection (2 doses); 40% reduction of viral load https://t.co/tI6LECbw42 pic.twitter.com/y85Vd9ih5A— Eric Topol (@EricTopol) June 30, 2021
Série de casos | Miocardite após imunização com vacinas de mRNA contra COVID-19.
30 Jun, 2021 | 10:47hVer também: Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination – JAMA Cardiology
Editoriais: Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines E Temporal Associations Between Immunization With the COVID-19 mRNA Vaccines and Myocarditis: The Vaccine Safety Surveillance System Is Working
Comentário: More Evidence Links Myocarditis to mRNA COVID-19 Vaccines – TCTMD
Comentário no Twitter
2 new reports of myocarditis after mRNA vaccination documenting its rare occurrence
23 males serving in the military among 2.8 million doses givenhttps://t.co/yPbYxkuSHi
4 cases in North Carolina, including a 70-year-old womanhttps://t.co/Iwj2Hx6O2U@JAMACardio pic.twitter.com/fv2JoOFAyt— Eric Topol (@EricTopol) June 29, 2021
Exclusivo | OMS estima que sejam necessárias doses anuais de reforço das vacinas contra COVID-19 para os mais vulneráveis.
30 Jun, 2021 | 10:45hExclusive-WHO estimates COVID-19 boosters needed yearly for most vulnerable – Reuters
Relacionado: CDC group says there isn’t enough data yet to recommend Covid booster shots – CNBC
Devo tomar a segunda dose da vacina da AstraZeneca? Sim; ela quase dobra sua proteção contra a variante Delta.
30 Jun, 2021 | 10:41hRelacionado: Effectiveness of COVID-19 vaccines against the B.1.617.2 variant – medRxiv
Estudo randomizado fase 1/2 | CoronaVac é bem tolerada, segura e induz forte resposta humoral em crianças e adolescentes de 3 a 17 anos de idade.
29 Jun, 2021 | 09:54hComentário convidado: COVID-19 vaccines for children younger than 12 years: are we ready? – The Lancet Infectious Diseases
Comentário no Twitter
NEW—A phase 1/2 clinical trial of #CoronaVac in 550 children and adolescents aged 3-17 years in China suggests two doses of the vaccine are safe and generate a strong antibody response. Read in @TheLancetInfDis: https://t.co/eXSagRu1Cs pic.twitter.com/fOKNLUjNwc
— The Lancet (@TheLancet) June 28, 2021


